172
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis

, , , , , , , & show all

References

  • Bárdos H, Juhász A, Répássy G, Adány R. 1998Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx. Thrombosis Haemostasis 80:767–772.
  • Bárdos H, Molnár P, Csécsei G, Adány R. 1996Fibrin deposition in primary and metastatic human brain tumours. Blood Coagulation & Fibrinolysis 7:536–548.
  • Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. 2004. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104:397–401.
  • Costantini V, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM. 1991Fibrinogen deposition without thrombin generation in primary human breast cancer tissue. Cancer Research 51:349–353.
  • Dvorak HF. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. New England Journal of Medicine 315:1650–1659.
  • Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, et al. 2011. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Molecular Pharmacology. 8:1538–1548.
  • Ghezzi F, Cromi A, Siesto G, Giudici S, Serati M, Formenti G, Franchi M. 2010a. Prognostic significance of preoperative plasma fibrinogen in endometrial cancer. Gynecologic Oncology 119:309–313.
  • Ghezzi F, Cromi A, Bergamini V, Uccella S, Beretta P, Franchi M, et al. 2006b. Laparoscopic management of endometrial cancer in nonobese and obese women: A consecutive series. Journal of Minimally Invasive Gynecology 13:269–275.
  • Hollborn M, Petto C, Steffen A, Trettner S, Bendig A, Wiedemann P, et al. 2009. Effects of thrombin on RPE cells are mediated by transactivation of growth factor receptors. Investigative Ophthalmology & Visual Science.; 50:4452–4459
  • Kalweit GA, Feindt P, Micek M, Gams E, Hellstern P. 2001. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood. Thrombosis Research 97:105–111.
  • Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. 2013. Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma. Oncology. 85:269–277.
  • Koressaar T, Remm M. 2007. Enhancements and modifications of primer design program Primer3. Bioinformatics. 23(10):1289–1291
  • Lee SY, Lee KP, Lim JW. 1996. Identification and biosynthesis of fibrinogen in human uterine cervix carcinoma cells. Thrombosis Haemostasis 75:466–470.
  • Molmenti EP, Ziambaras T, Perlmutter DH. 1993. Evidence for an acute phase response in human intestinal epithelial cells. The Journal of Biological Chemistry 268:14116–14124.
  • Palumbo JS, Kombrinck KW, Drew AF, Grimes TS, Kiser JS, Degen JL, et al. 2000. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96:3302–3309.
  • Pichler M, Hutterer GC, Stojakovic T, Mannweiler S, Pummer K, Zigeuner R. 2013. High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. British Journal of Cancer 109:1123–1129.
  • Polterauer S, Grimm C, Seebacher V, Concin N, Marth C, Tomovski C, et al. 2009aPlasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study. Oncologist 14:979–985.
  • Polterauer S, Seebacher V, Hefler-Frischmuth K, Grimm C, Heinze G, Tempfer C, et al. 2009bFibrinogen plasma levels are an independent prognostic parameter in patients with cervical cancer. American Journal of Obstetrics and Gynecology 200:647.e1–7.
  • Seebacher V, Polterauer S, Grimm C, Tempfer C, Hefler-Frischmuth K, Reinthaller A, et al. 2012. The impact of plasma fibrinogen levels on patients with vulvar cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology 161:88–91.
  • Seebacher V, Polterauer S, Grimm C, Husslein H, Leipold H, Hefler-Frischmuth K, et al. 2010. The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial. British Journal of Cancer 102:952–956.
  • Sheng L, Luo M, Sun X, Lin N, Mao W, Su D. 2013. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. International Journal of Cancer. 133:2720–2725.
  • Siegel R, Naishadham D, Jemal A. 2013. Cancer Statistics, 2013. CA A Cancer Journal for Clinicians. 63:11–30.
  • Silverberg E, Lubera J. 1987. Cancer statistics, 1987. CA A Cancer Journal for Clinicians 37:2–19.
  • Simpson-Haidaris PJ, Rybarczyk B. 2001. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Annals of the New York Academy of Science. 936:406–425.
  • Sohaib SA, Houghton SL, Meroni R, Rockall AG, Blake P, Reznek RH. 2007. Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis. Clinical Radiology. 62:28–34
  • Suh DH, Kim HS, Chung HH, Kim JW, Park NH, Song YS, et al. 2012. Pre-operative systemic inflammatory response markers in predicting lymph node metastasis in endometrioid endometrial adenocarcinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology 162:206–210.
  • Uccella S, Cromi A, Bogani G, Casarin J, Formenti G, Ghezzi F. 2013. Systematic implementation of laparoscopic hysterectomy independent of uterus size: clinical effect. Journal of Minimally Invasive Gynecology 20:505–516.
  • Weisel JW. 2005. Fibrinogen and fibrin. Advances in Protein 70:247–299.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.